穴位埋线联合自拟中药汤剂口服治疗慢性浅表性胃炎疗效观察

Therapeutic effects of acupoint embedding plus TCM decoction on chronic superficial gastritis

目的:穴位埋线联合中药汤剂口服治疗慢性浅表性胃炎的疗效观察。方法:本次所有研究对象均来自于我院2015年1月-2017年12月所收治的60例慢性浅表性胃炎患者,将所有患者按照数字随机的方式分成两组,每组各30例。对照组患者采用西药治疗,治疗组使用穴位埋线联合中药汤剂口服治疗,对比两组临床疗效。结果:治疗组患者临床治疗总有效率为96.67%,而对照组患者临床总有效率为66.67%,组间数据比较差异具有统计学意义,P <0.05,治疗组明显优于对照组。两组患者治疗前临床症状评分数据比较差异无统计学意义,P> 0.05;治疗后对照组为(5.32±0.45)分,明显高于对治疗组的(2.34±0.34)分,组间数据比较差异具有统计学意义(P <0.05)。治疗后,治疗组、对照组CD3^+、CD4^+及CD4^+/CD8^+水平均显著高于治疗前,P <0.05,但治疗组治疗后CD3^+、CD4^+及CD4^+/CD8^+水平更高,P <0.05。结论:穴位埋线联合中药汤剂口服治疗慢性浅表性胃炎患者价值显著,能够最大程度提高临床疗效,同时还能有效改善临床各项症状,值得推广使用。

Objective:To observe the effects of acupoint embedding plus TCM decoction on chronic superficial gastritis.Methods:60 patients were randomly divided into two groups,30 patients in each.The patients in the control group were treated with western medicine.The treatment group was given acupoint embedding plus herbal decoction,and the clinical efficacy in two groups was compared.The total effective rate in the treatment group was 96.67%,significantly better than 66.67%in the control group(P<0.05).There was no significant difference in the clinical symptom scores between two groups before treatment(P>0.05).After treatment,the control group was(5.32±0.45)points,significantly higher than(2.34±0.34)in the treatment group(P<0.05).After treatment,the levels of CD3^+,CD4^+and CD4^+/CD8^+in the two groups were significantly higher than before treatment(P<0.05).And the levels of CD3^+,CD4^+and CD4^+/CD8^+in the treatment group were higher(P<0.05).Conclusion:Acupoint embedding plus TCM decoction can improve the clinical efficacy on chronic superficial gastritis,can effectively improve the clinical symptoms,and is worthy of promotion.